Helicos Seeks to Raise $6.4M in Direct Offering

Helicos will use the funds for R&D efforts and general corporate purposes. Its shares tumbled in response to the offering.

Full-text access for registered users only. Existing users login here.
New to GenomeWeb? Register here quickly for free access.